Sua seleção (0)
Detalhe da pesquisa
1.
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma.
Blood;
132(10): 1022-1026, 2018 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925499
2.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer;
2019 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
3.
Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy.
Br J Haematol;
2019 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804715
4.
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.
Oncologist;
24(7): 955-962, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568021
5.
Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma.
Am J Hematol;
2019 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804739
6.
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Blood;
128(18): 2199-2205, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601462
7.
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
Am J Hematol;
92(9): 879-884, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512788
8.
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Cancer;
122(4): 559-64, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26565895
9.
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Br J Haematol;
175(4): 631-640, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469075
10.
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Blood;
124(15): 2354-61, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161267
11.
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
Am J Hematol;
91(7): 672-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27012928
12.
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.
Biol Blood Marrow Transplant;
21(2): 335-41, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445028
13.
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.
Br J Haematol;
170(4): 504-14, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907897
14.
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.
Br J Haematol;
166(3): 369-74, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24761809
15.
A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib.
Blood;
2017 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28794071
16.
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
Am J Hematol;
88(8): 657-60, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23640768
17.
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
Br J Haematol;
174(2): 332-4, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403537
18.
Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?
Br J Haematol;
165(1): 145-6, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24354694
19.
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.
Clin Lymphoma Myeloma Leuk;
19(7): e393-e398, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31053549
20.
Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use.
Clin Lymphoma Myeloma Leuk;
19(12): 791-798, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648953